Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Assets (2016 - 2025)

Historic Assets for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $1.0 billion.

  • Tg Therapeutics' Assets rose 7491.46% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 7491.46%. This contributed to the annual value of $577.7 million for FY2024, which is 7527.69% up from last year.
  • According to the latest figures from Q3 2025, Tg Therapeutics' Assets is $1.0 billion, which was up 7491.46% from $702.6 million recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Assets peaked at $1.0 billion during Q3 2025, and registered a low of $193.6 million during Q4 2022.
  • Moreover, its 5-year median value for Assets was $379.6 million (2021), whereas its average is $430.9 million.
  • Per our database at Business Quant, Tg Therapeutics' Assets skyrocketed by 43873.77% in 2021 and then crashed by 4901.02% in 2022.
  • Over the past 5 years, Tg Therapeutics' Assets (Quarter) stood at $379.6 million in 2021, then tumbled by 49.01% to $193.6 million in 2022, then surged by 70.27% to $329.6 million in 2023, then surged by 75.28% to $577.7 million in 2024, then skyrocketed by 77.43% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $702.6 million for Q2 2025, and $656.7 million during Q1 2025.